Literature DB >> 6537802

Increased tissue deposition and decreased excretion of platinum following administration of cisplatin to cisplatin-pretreated animals.

C L Litterst, V G Schweitzer.   

Abstract

Guinea pigs were pretreated IP with cisplatin (10 mg/kg) for various times before IV administration of 195mPt-labeled cisplatin. Concentrations of 195mplatinum were greater in tissues of pretreated animals than in those of control animals. Amounts of 195mplatinum in subcellular fractions from pretreated rabbits were similarly greater in pretreated animals. Amounts of radioactivity appeared to be greatest in animals receiving a larger number of pretreatment injections, even though the total amount of cisplatin administered was equal in all groups. BUN was elevated on day 1 after the radioactive dose only in those animals which had been pretreated. Urinary excretion of platinum was significantly less in pretreated than in control animals. It appears that pretreatment with cisplatin damages the kidney severely enough for subsequent doses of cisplatin not to be excreted as efficiently, thus leading to a greater tissue deposition of platinum in pretreated animals.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6537802     DOI: 10.1007/bf00255909

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  9 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry.

Authors:  A F LeRoy; M L Wehling; H L Sponseller; W S Friauf; R E Solomon; R L Dedrick; C L Litterst; T E Gram; A M Guarino; D A Becker
Journal:  Biochem Med       Date:  1977-10

3.  Studies on metal-binding proteins of low molecular weight from renal tissue of rabbits exposed to cadmium or mercury.

Authors:  M Nordbery; B Trojanowska; G F Nordberg
Journal:  Environ Physiol Biochem       Date:  1974

4.  The preparation of red cell ghosts (membranes).

Authors:  D J Hanahan; J E Ekholm
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

5.  Equine hepatic and renal metallothioneins. Purification, molecular weight, amino acid composition, and metal content.

Authors:  J H Kägi; S R Himmelhoch; P D Whanger; J L Bethune; B L Vallee
Journal:  J Biol Chem       Date:  1974-06-10       Impact factor: 5.157

6.  Ototoxic and nephrotoxic effects of combined treatment with cis-diamminedichloroplatinum and kanamycin in the guinea pig.

Authors:  V G Schweitzer; J E Hawkins; D J Lilly; C J Litterst; G Abrams; J A Davis; M Christy
Journal:  Otolaryngol Head Neck Surg       Date:  1984-02       Impact factor: 3.497

7.  Influence of certain metals on the level of metallothionein-like proteins in the liver and kidneys of rats.

Authors:  J K Piotrowski; J A Szymańska
Journal:  J Toxicol Environ Health       Date:  1976-07

8.  Acute renal failure after cis-dichlorodiammineplatinum(II) and gentamicin-cephalothin therapies.

Authors:  J C Gonzalez-Vitale; D M Hayes; E Cvitkovic; S S Sternberg
Journal:  Cancer Treat Rep       Date:  1978-05

9.  Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.

Authors:  C L Litterst; T E Gram; R L Dedrick; A F Leroy; A M Guarino
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

  9 in total
  9 in total

1.  Shape changes induced by N-terminal platination of ubiquitin by cisplatin.

Authors:  Jonathan P Williams; Hazel I A Phillips; Iain Campuzano; Peter J Sadler
Journal:  J Am Soc Mass Spectrom       Date:  2010-02-11       Impact factor: 3.109

Review 2.  Cisplatinum: a review, with special reference to cellular and molecular interactions.

Authors:  C L Litterst
Journal:  Agents Actions       Date:  1984-12

3.  Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.

Authors:  N M Osman; M P Copley; C L Litterst
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  Cisplatin-associated anemia: an erythropoietin deficiency syndrome.

Authors:  P A Wood; W J Hrushesky
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

5.  Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.

Authors:  D J Stewart; C Dulberg; J M Molepo; N Z Mikhael; V A Montpetit; M D Redmond; R Goel
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.

Authors:  J D Holding; W E Lindup; D A Bowdler; M Z Siodlak; P M Stell
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

7.  The effect of cisplatin on renal ATPase activity in vivo and in vitro.

Authors:  J Uozumi; C L Litterst
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

8.  Correlations between cis-platinum dosage and toxicity in a guinea pig model.

Authors:  L J Hoeve; I R Mertens zur Borg; M Rodenburg; M P Brocaar; B G Groen
Journal:  Arch Otorhinolaryngol       Date:  1988

9.  Long-term pharmacokinetic behavior of platinum after cisplatin administration.

Authors:  E Gamelin; P Allain; P Maillart; A Turcant; R Delva; A Lortholary; F Larra
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.